EP Patent

EP0136011A2 — A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor

Assigned to Pre Jay Holdings Ltd · Expires 1985-04-03 · 41y expired

What this patent protects

Pharmaceutical compositions comprise an estrogen and a progestogen, generally in the form of a unit dosage containing both or a pack containing unit dosages of each. The size of each unit dosage is normally between 0.005 mg and 2.5 mg estrogen and 0.25 mg and 30 mg progestogen. S…

USPTO Abstract

Pharmaceutical compositions comprise an estrogen and a progestogen, generally in the form of a unit dosage containing both or a pack containing unit dosages of each. The size of each unit dosage is normally between 0.005 mg and 2.5 mg estrogen and 0.25 mg and 30 mg progestogen. Slow release compositions may provide similar dosages. The administration of these low dosages continuously, or of progestogen continuously and estrogen for periods of 20 to 120 days followed by an interval of 3 to 7 days, is useful for treating menopausal (including peri- menopausal and post-menopausal) disorders in women.

Drugs covered by this patent

Patent Metadata

Patent number
EP0136011A2
Jurisdiction
EP
Classification
—
Expires
1985-04-03
Drug substance claim
No
Drug product claim
No
Assignee
Pre Jay Holdings Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.